Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
01/2013
01/02/2013CN102188501B Rhubarb anthraquinones component extracting and separating method
01/02/2013CN102153543B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
01/02/2013CN102068426B New application of Ginkgolide B derivative in medicament preparation
01/02/2013CN102058540B Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof
01/02/2013CN101830889B 嘧啶衍生物 Pyrimidine derivatives
01/01/2013US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
01/01/2013US8344003 2-pyridinecarboxamide derivatives
01/01/2013US8343988 Inhibitors of histone deacetylase
01/01/2013US8343763 Heterocyclic derivatives as modulators of ion channels
01/01/2013US8343544 Oral sustained-release tablet
12/2012
12/27/2012WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/27/2012WO2012176009A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012WO2012127495A3 Pharmaceutical composition and process for preparation thereof
12/27/2012US20120329886 Use of periostin as a novel biomarker
12/27/2012US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
12/27/2012US20120329844 Valsartan salts
12/27/2012US20120329834 Compounds for the treatment of mitochondrial diseases
12/27/2012US20120329802 Metalloenzyme inhibitor compounds
12/27/2012US20120329760 Rnase 7 as a marker for infection
12/27/2012US20120329727 Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/27/2012US20120329717 Novel omega conotoxin peptides
12/27/2012US20120329716 Yellow pea seed protein-derived peptides
12/27/2012US20120328712 Carbon monoxide releasing rhenium compounds for medical use
12/27/2012US20120328702 Nanoparticle compositions
12/27/2012US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor
12/27/2012US20120328639 Immunogenic lhrh compositions and methods relating thereto
12/27/2012US20120328634 Immunoconjugates with an Intracellularly-Cleavable Linkage
12/27/2012US20120328632 Inhibition of leukocyte adhesion
12/27/2012US20120328617 Method for inhibiting angiogenesis
12/27/2012US20120328573 Composition for Maintaining Healthy Kidney Function
12/27/2012US20120328525 Nanoparticle compositions and components thereof
12/27/2012CA2877586A1 Treatment and prevention of diseases related to oxidative stress
12/27/2012CA2837178A1 Trpv1 antagonists including dihydroxy substituent and uses thereof
12/26/2012EP2537531A2 Composition for percutaneous administration of tolterodine with reduced skin irritation
12/26/2012EP2537516A2 Composition for percutaneous administration of tolterodine with improved skin permeation
12/26/2012EP2536415A1 Argon-based inhalable gaseous medicament against peripheral organ deficiencies or failures
12/26/2012CN202620279U Chinese herbal powder for treating kidney channel tissue diseases and packagage thereof
12/26/2012CN202620278U Relinqing tablet
12/26/2012CN102839097A Glossy privet fruit health wine with functions of liver tonifying and kidney tonifying
12/26/2012CN102839095A Common fenugreek seed health wine with functions of kidney warming and yang strengthening
12/26/2012CN102838671A Growth hormone with site-specific mutagenesis and site-specific decoration, preparation method and applications of growth hormone
12/26/2012CN102838596A Pyrrolo[2,3-b]pyridine derivative, preparation method and application thereof
12/26/2012CN102836404A Chinese medicine for treating chronic nephritis by using ludwigia octovalvis
12/26/2012CN102836403A Chinese medicine for treating chronic nephritis by using root of low greenbrier
12/26/2012CN102836393A Medicament for treating chronic nephritis through permeation and kidney-activating cell regeneration therapy
12/26/2012CN102836365A Chinese medicinal composition for treating urinary system calculi and application thereof
12/26/2012CN102836344A Traditional Chinese medicine preparation for treating kidney calculi
12/26/2012CN102836339A Medicine for treating diabetic nephropathy
12/26/2012CN102836329A Chinese medicinal composition for treating diabetic nephropathy
12/26/2012CN102836295A Medicine for uremia treatment and preparation method
12/26/2012CN102836284A Locust medicinal liquor
12/26/2012CN102836272A Medicinal composition for treating prostate hyperplasia
12/26/2012CN102836164A Combinatorial drug for preventing and curing benign prostatic hyperplasia
12/26/2012CN102836161A Medicament compound preparation formed by mixing olmesartan medoxomil with benzene sulfonic acid amlodipine and hydrochlorothiazide
12/26/2012CN102836145A Applications of pterostilbene in preparation of medicines for preventing and treating chronic glomerular disease
12/26/2012CN102516079B Synthetic method of novel ferulic acid derivative
12/26/2012CN102349897B Meropenem sodium/tazobactam sodium medicinal composition
12/26/2012CN102309709B Medicine for treating vesical calculus
12/26/2012CN102274253B Stone expelling medicine for urinary system
12/26/2012CN102258597B Preparation technique of tablets for removing prostate stagnation
12/26/2012CN102258492B Neostigmine bromide slow release preparation and its preparation method
12/26/2012CN102218132B Medicinal composition for treating nasal bleeding
12/26/2012CN102133272B Preparation method of granules for treating nephrolith
12/26/2012CN102038939B Preparation method of adenosine triphosphate coenzyme insulin freeze-dried powder injection
12/26/2012CN102038638B 盐酸克林霉素注射液及其制备方法 Clindamycin Hydrochloride Injection and its preparation method
12/26/2012CN101984314B Preparation method for dry extract of total saponins of rehmannia leaves
12/26/2012CN101313926B Transcription regulating and controlling article composition
12/26/2012CN101076521B Process for producing muscarine receptor antagonist and intermediate therefor
12/26/2012CN100998864B Cyclosporin A semisolid skeleton capsule
12/25/2012US8338478 Derivatives of 3,3-diphenylpropylamines
12/25/2012US8338401 Coumarin-amide derivatives and its preparation, said drug composition and its use
12/25/2012US8338370 Methods and compositions for promoting organ development
12/25/2012US8337884 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
12/25/2012US8337834 Methods of making enhanced, autologous fat grafts
12/20/2012WO2012173849A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/20/2012WO2012173226A1 Pharmaceutical preparation containing polystyrenesulfonic acid salt
12/20/2012WO2012173219A1 Novel biaryl ether derivative
12/20/2012WO2012173174A1 Azaspiroalkane compound
12/20/2012WO2012147107A3 Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
12/20/2012US20120322842 Heterocycyl-substituted-alkylaminophenyl derivatives, their preparation and use as medicaments
12/20/2012US20120322841 Aldosterone Synthase Inhibitor
12/20/2012US20120322810 New salts
12/20/2012US20120322809 Substituted oxindole derivatives and their use as vasopressin receptor ligands
12/20/2012US20120322801 Heterocyclic amides as rock inhibitors
12/20/2012US20120322795 Biarylamide inhibitors of leukotriene production
12/20/2012US20120322790 Pyrazolopiperidine Compounds As CCR1 Receptor Antagonists
12/20/2012US20120322787 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/20/2012US20120322778 Pharmaceutical compositions
12/20/2012US20120322772 Substituted imidazopyrimidines and triazolopyrimidines
12/20/2012US20120322734 Pharmaceutical Compositions Including Low Dosages of Desmopressin
12/20/2012US20120321690 Adhesive patch
12/20/2012US20120321668 PEPTIDES DERIVED FROM HIV-1 gp41 TRANSMEMBRANE
12/20/2012US20120321651 Anti-IGE Vaccines
12/20/2012US20120321629 Stem cell factor inhibitor
12/20/2012US20120321603 Composition and method for stabilization and delivery of therapeutic molecules
12/20/2012US20120321591 Anti-angiogenic compounds
12/20/2012US20120321564 Compositions Useful for Reducing Nephrotoxicity and Methods of Use Thereof
12/20/2012CA2836804A1 Pyrazole derivatives useful as aldosterone synthase inhibitors
12/19/2012EP2535051A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
12/19/2012EP2535047A1 Nutritional composition, food supplement comprising said nutritional composition and kit comprising said food supplement
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 562